You are here: Home » International » News » Others
Business Standard

World coronavirus dispatch: First human trial of Covid-19 drug underway

From the first human trial volunteer, to the Donald Trump prescription that sent the medical world into a tizzy, and the confusion around China's tally - read these and more in today's world dispatch

Coronavirus | Lockdown

Yuvraj Malik  |  New Delhi 

Healthcare workers
FILE PIC: Healthcare workers walk outside NYU Langone Medical Center in Manhattan in New York City. Photo: Reuters

A UK woman on Thursday became the first volunteer to participate in the human trial for a coronavirus vaccine, an event that marks a new stride in the world’s fight against the pandemic. Elisa Granato was one of the two volunteers injected with the drug developed at the Oxford University. A larger trial, of about 5,000 volunteers, will start in the coming months. Read more here.



What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.


Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sat, April 25 2020. 06:18 IST